Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 27, 2022

BUY
$0.13 - $76.84 $2 - $1,613
21 New
21 $1,000
Q1 2022

May 04, 2022

SELL
$61.48 - $73.72 $2,459 - $2,948
-40 Closed
0 $0
Q4 2021

Jan 28, 2022

BUY
$53.63 - $62.52 $2,145 - $2,500
40 New
40 $2.49 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Absolute Capital Management, LLC Portfolio

Follow Absolute Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Absolute Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Absolute Capital Management, LLC with notifications on news.